Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis.
about
An update on cladribine for relapsing-remitting multiple sclerosis.Ocrelizumab: a B-cell depleting therapy for multiple sclerosis.Both cladribine and alemtuzumab may effect MS via B-cell depletionA B Cell-Driven Autoimmune Pathway Leading to Pathological Hallmarks of Progressive Multiple Sclerosis in the Marmoset Experimental Autoimmune Encephalomyelitis Model.Cladribine to treat disease exacerbation after fingolimod discontinuation in progressive multiple sclerosis.In Silico Prediction Analysis of Idiotope-Driven T-B Cell Collaboration in Multiple Sclerosis.Role of Immunological Memory Cells as a Therapeutic Target in Multiple Sclerosis.Transcriptome profiling of peripheral blood immune cell populations in multiple sclerosis patients before and during treatment with a sphingosine-1-phosphate receptor modulator.Transcriptional profile and Epstein-Barr virus infection status of laser-cut immune infiltrates from the brain of patients with progressive multiple sclerosis.Alemtuzumab depletion failure can occur in multiple sclerosis.Comparative effectiveness of rituximab relative to IFN-β or glatiramer acetate in relapsing-remitting MS from the Swedish MS registry.Emerging Understanding of the Mechanism of Action for Dimethyl Fumarate in the Treatment of Multiple Sclerosis.Inflammation in CNS Neurodegenerative Diseases.Cladribine treatment of multiple sclerosis is associated with depletion of memory B cells.Impact of Glatiramer Acetate on B Cell-Mediated Pathogenesis of Multiple SclerosisSingle cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populationsRole of CXCL13 in the formation of the meningeal tertiary lymphoid organ in multiple sclerosis
P2860
Q38600051-0D98AC0C-FCC3-4EAC-B7F9-F2F7024AC6FCQ38665518-2C1784A3-C1B9-4200-ACE2-8281C2E0EB7EQ38720045-A4EBA4BD-8E36-4D44-AAB0-FE03029B216BQ39458392-A536F144-154A-417B-A9AD-DC5EE89D264AQ40962421-716F80B0-F6FD-458E-9244-848053C7894EQ42371905-E3CE10C3-9F99-4DB5-9ACD-04003BE4EE4CQ47130362-67678906-A72D-4DF8-AD81-F889227365C5Q47191107-FD1E5345-00FA-4492-8E08-F2823B9C00D8Q47552983-B127F7A6-17F0-47E5-B54A-4F8127B0D017Q48106234-2DECFAAC-0033-4C14-AA56-99F46E34C10CQ48224174-F2D2B6F6-624B-45A1-8A23-0148CBFA5006Q49800939-870958D2-0968-4C9F-A060-E1966F5F5C83Q51765219-BC1A2550-9C36-4A15-BC15-C5BA95DA8D8DQ52650355-B3A88E9D-77EF-4753-ABB4-33A78A7EA11AQ57470698-9EA634E2-6E29-4CAF-80A3-030BA8D95965Q57804774-B31124EB-40A2-4127-BB9C-F13167C4BDDAQ57825780-202AFEC7-8AF1-4B2E-8091-9DDD2C6EC297
P2860
Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Memory B Cells are Major Targe ...... Relapsing Multiple Sclerosis.
@en
Memory B Cells are Major Targe ...... Relapsing Multiple Sclerosis.
@nl
type
label
Memory B Cells are Major Targe ...... Relapsing Multiple Sclerosis.
@en
Memory B Cells are Major Targe ...... Relapsing Multiple Sclerosis.
@nl
prefLabel
Memory B Cells are Major Targe ...... Relapsing Multiple Sclerosis.
@en
Memory B Cells are Major Targe ...... Relapsing Multiple Sclerosis.
@nl
P2093
P2860
P921
P1433
P1476
Memory B Cells are Major Targe ...... Relapsing Multiple Sclerosis.
@en
P2093
David Baker
Gareth Pryce
Klaus Schmierer
P2860
P356
10.1016/J.EBIOM.2017.01.042
P5008
P577
2017-01-31T00:00:00Z
2017-02-01T00:00:00Z